These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29752869)

  • 1. Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study.
    Laskowitz DT; Bennett ER; Durham RJ; Volpi JJ; Wiese JR; Frankel M; Shpall E; Wilson JM; Troy J; Kurtzberg J
    Stem Cells Transl Med; 2018 Jul; 7(7):521-529. PubMed ID: 29752869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke.
    Laskowitz DT; Troy J; Poehlein E; Bennett ER; Shpall EJ; Wingard JR; Freed B; Belagaje SR; Khanna A; Jones W; Volpi JJ; Marrotte E; Kurtzberg J
    Stem Cells Transl Med; 2024 Feb; 13(2):125-136. PubMed ID: 38071749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Restoration of Motor Function in Acute Cerebral Stroke Treated with Allogeneic Human Umbilical Cord Blood Monocytes: Preliminary Results of a phase I Clinical Trial.
    Lee TK; Lu CY; Tsai ST; Tseng PH; Lin YC; Lin SZ; Wang JC; Huang CY; Chiu TL
    Cell Transplant; 2021; 30():9636897211067447. PubMed ID: 34939863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: a systematic review of clinical studies.
    Paton MCB; Wall DA; Elwood N; Chiang KY; Cowie G; Novak I; Finch-Edmondson M
    Cytotherapy; 2022 Jan; 24(1):2-9. PubMed ID: 34384698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human allogeneic AB0/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy.
    Romanov YA; Tarakanov OP; Radaev SM; Dugina TN; Ryaskina SS; Darevskaya AN; Morozova YV; Khachatryan WA; Lebedev KE; Zotova NS; Burkova AS; Sukhikh GT; Smirnov VN
    Cytotherapy; 2015 Jul; 17(7):969-78. PubMed ID: 25791070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults.
    Hamza NS; Lisgaris M; Yadavalli G; Nadeau L; Fox R; Fu P; Lazarus HM; Koc ON; Salata RA; Laughlin MJ
    Br J Haematol; 2004 Feb; 124(4):488-98. PubMed ID: 14984500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
    Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
    J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.
    Kanda J; Ichinohe T; Kato S; Uchida N; Terakura S; Fukuda T; Hidaka M; Ueda Y; Kondo T; Taniguchi S; Takahashi S; Nagamura-Inoue T; Tanaka J; Atsuta Y; Miyamura K; Kanda Y;
    Leukemia; 2013 Feb; 27(2):286-94. PubMed ID: 22806066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sibling umbilical cord blood infusion is safe in young children with cerebral palsy.
    Sun JM; Case LE; Mikati MA; M Jasien J; McLaughlin C; Waters-Pick B; Worley G; Troy J; Kurtzberg J
    Stem Cells Transl Med; 2021 Sep; 10(9):1258-1265. PubMed ID: 34085782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical Cord Blood Transplantation Is a Feasible Rescue Therapeutic Option for Patients Suffering from Graft Failure after Previous Hematopoietic Stem Cell Transplantation.
    Bojic M; Worel N; Sperr WR; Schellongowski P; Wohlfarth P; Schwarzinger I; Mitterbauer-Hohendanner G; Fischer G; Dieckmann KU; Lamm W; Leiner M; Schulenburg A; Mitterbauer M; Greinix HT; Kalhs P; Rabitsch W
    Oncology; 2016; 90(3):160-6. PubMed ID: 26871562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
    Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
    Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
    van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
    Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HLA in cord blood transplantation outcomes.
    Ruggeri A; Paviglianiti A; Gluckman E; Rocha V
    HLA; 2016 Jun; 87(6):413-21. PubMed ID: 27060588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of cord blood cell therapy with erythropoietin for children with CP: a 2 × 2 factorial randomized placebo-controlled trial.
    Min K; Suh MR; Cho KH; Park W; Kang MS; Jang SJ; Kim SH; Rhie S; Choi JI; Kim HJ; Cha KY; Kim M
    Stem Cell Res Ther; 2020 Nov; 11(1):509. PubMed ID: 33246489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical safety in using unmatched allogeneic umbilical cord blood mononuclear cells transplantations in non-haematopoietic degenerative conditions.
    Vyas R; Dudhat D; Navik P; Sudhalkar N; Garg V; Thadani J; Marathe A; Bhonde R; Vyas B; Deb K
    J Stem Cells; 2014; 9(4):219-24. PubMed ID: 25942337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
    Tsai SB; Rhodes J; Liu H; Shore T; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
    Biol Blood Marrow Transplant; 2018 May; 24(5):997-1004. PubMed ID: 29288821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.